Welcome to our dedicated page for Iqvia Hldgs SEC filings (Ticker: IQV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how IQVIA turns billions of clinical data points into revenue can feel like decoding a medical registry. Key figures on contract research backlogs, technology licensing, and goodwill impairment are scattered across dense reports, and keeping up with IQVIA insider trading Form 4 transactions adds another layer of complexity. Investors who type 鈥�IQVIA SEC filings explained simply鈥� need more than raw documents鈥攖hey need answers. Stock Titan鈥檚 AI reads every line the moment it hits EDGAR and highlights what matters.
Whether you鈥檙e hunting for the latest IQVIA quarterly earnings report 10-Q filing, comparing cash-flow trends inside an IQVIA annual report 10-K simplified, or needing IQVIA Form 4 insider transactions real-time, our platform delivers. We pair line-by-line machine learning with human-trained models, turning raw data into plain-English takeaways. Drill into revenue by segment, R&D capitalization, or debt covenants in seconds鈥�understanding IQVIA SEC documents with AI becomes straightforward. Each page also links to thorough IQVIA earnings report filing analysis prepared by our research desk, so you can move from numbers to narrative without opening a spreadsheet.
Looking beyond quarterly results, Stock Titan monitors every event that could move the share price. Receive instant alerts when IQVIA 8-K material events explained鈥攖hink acquisitions, data breaches, or leadership changes鈥攁re posted. Explore IQVIA executive stock transactions Form 4 to gauge management sentiment, and review the IQVIA proxy statement executive compensation section to see how performance metrics align with pay. With real-time updates, AI-powered summaries, and historical search across all forms, you鈥檒l spend less time digging and more time deciding.
Harris Associates L.P. and Harris Associates, Inc. filed an Amendment No. 1 to Schedule 13G reporting beneficial ownership of IQVIA Holdings Inc. common stock. The filing shows an aggregate of 11,753,182 shares, representing 6.8% of the class, with sole voting power over 10,291,782 shares and sole dispositive power over 11,753,182 shares. The Schedule identifies IQVIA's principal executive office at 2400 Ellis Road, Durham, NC.
The statement notes the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The filing is dated as an event on 06/30/2025 and signed on 08/14/2025 by Joseph J. Allessie as General Counsel and Secretary.
IQVIA Holdings Inc. (IQV) filed a Form 4 showing that Senior Vice President & Corporate Controller Keriann Cherofsky sold 549 common shares on 07/23/2025 at $191.53 per share, a transaction valued at roughly $105k. After the sale, her direct ownership stands at 2,910 shares; no derivative securities were involved.
The disposition reduced her direct stake by about 16% (549 of ~3,459 prior shares). While small relative to IQV鈥檚 market capitalization and daily trading volume, insider sales can be perceived as a modestly bearish signal because executives possess superior insight into company prospects. No accompanying purchases, option exercises, or material company events were reported in this filing.
FAQ
What is the current stock price of Iqvia Hldgs (IQV)?
What is the market cap of Iqvia Hldgs (IQV)?
